Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Ryohei Katayama · SciRah

Researcher profile · Semantic Scholar

Ryohei Katayama

Share profile

Ryohei Katayama — researcher profile on SciRah

h-index: 42
Works: 174
Citations: 13K

Most-cited papers

Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer
B. Gong, K. Kiyotani, S. Sakata, S. Nagano +10 more
2019Journal of Experimental Medicine229 citations Open access
Semantic Scholar
Prediction of ALK mutations mediating ALK-TKIs resistance and drug re-purposing to overcome the resistance
Koutaroh Okada, M. Araki, T. Sakashita, Biao Ma +13 more
2019EBioMedicine128 citations Open access
Semantic Scholar
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer
H. Mizuta, Koutaroh Okada, M. Araki, J. Adachi +20 more
2021Nature Communications95 citations Open access
Semantic Scholar
Epithelial-to-Mesenchymal Transition Is a Mechanism of ALK Inhibitor Resistance in Lung Cancer Independent of ALK Mutation Status.
K. Fukuda, S. Takeuchi, S. Arai, Ryohei Katayama +16 more
2019Cancer Research94 citations
Semantic Scholar
U.S. Phase I First-in-human Study of Taletrectinib (DS-6051b/AB-106), a ROS1/TRK Inhibitor, in Patients with Advanced Solid Tumors
K. Papadopoulos, E. Borazanci, A. Shaw, Ryohei Katayama +20 more
2020Clinical Cancer Research79 citations
Semantic Scholar
Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation
Ray Sagawa, S. Sakata, B. Gong, Yosuke Seto +15 more
2021JCI Insight48 citations Open access
Semantic Scholar
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
S. Takagi, Yukio Sasaki, S. Koike, Ai Takemoto +11 more
2021Oncogene46 citations Open access
Semantic Scholar
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
N. Yanagitani, K. Uchibori, S. Koike, M. Tsukahara +9 more
2020Cancer Science46 citations Open access
Semantic Scholar
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer
Ken Takahashi, Yosuke Seto, Koutaroh Okada, Shinya Uematsu +8 more
2020Thoracic Cancer36 citations Open access
Semantic Scholar
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer
Yuki Katayama, Tadaaki Yamada, K. Tanimura, Shinsaku Tokuda +20 more
2023npj Precision Oncology34 citations Open access
Semantic Scholar
Osimertinib overcomes alectinib resistance caused by amphiregulin in a leptomeningeal carcinomatosis model of ALK-rearranged lung cancer.
S. Arai, S. Takeuchi, K. Fukuda, H. Taniguchi +15 more
2020Journal of Thoracic Oncology28 citations Open access
Semantic Scholar
descSPIM: an affordable and easy-to-build light-sheet microscope optimized for tissue clearing techniques
Kohei Otomo, Takaki Omura, Y. Nozawa, Steven Edwards +40 more
2024Nature Communications24 citations Open access
Semantic Scholar
Targeting Podoplanin for the Treatment of Osteosarcoma
Ai Takemoto, S. Takagi, Takao Ukaji, N. Gyobu +16 more
2022Clinical Cancer Research23 citations Open access
Semantic Scholar
Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
Takahiro Yoshizawa, K. Uchibori, M. Araki, S. Matsumoto +16 more
2021npj Precision Oncology23 citations Open access
Semantic Scholar
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features
K. Tanimura, Tadaaki Yamada, Koutaroh Okada, Kunihiro Nakai +21 more
2022npj Precision Oncology20 citations Open access
Semantic Scholar
Ultra‐Rapid and Specific Gelation of Collagen Molecules for Transparent and Tough Gels by Transition Metal Complexation
Tomoyuki Suezawa, Naoko Sasaki, Yuichi Yukawa, Nazgul Assan +8 more
2023Advancement of science19 citations Open access
Semantic Scholar
Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization
Kohei Maruyama, Yuki Shimizu, Yumi Nomura, Tomoko Oh-hara +4 more
2025npj Precision Oncology16 citations Open access
Semantic Scholar
Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trial
T. Yoshida, T. Kumagai, R. Toyozawa, Ryohei Katayama +9 more
2023Cancer Science16 citations Open access
Semantic Scholar
A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer
Mai Suzuki, K. Uchibori, T. Oh-hara, Yumi Nomura +12 more
2024npj Precision Oncology15 citations Open access
Semantic Scholar
GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer
Yuki Shimizu, Koutaroh Okada, J. Adachi, Yuichi Abe +8 more
2022npj Precision Oncology15 citations Open access
Semantic Scholar
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
Yuki Shimizu, Kohei Maruyama, Masako Suzuki, H. Kawachi +6 more
2022Cancer Letters15 citations Open access
Semantic Scholar
A case of hyperprogressive disease following atezolizumab therapy for pulmonary pleomorphic carcinoma with epidermal growth factor receptor mutation
T. Oguri, S. Sasada, S. Seki, Saori Murata +7 more
2021Respiratory Medicine Case Reports15 citations Open access
Semantic Scholar
Improvement in predicting drug sensitivity changes associated with protein mutations using a molecular dynamics based alchemical mutation method
Fumie Ono, S. Chiba, Yuta Isaka, S. Matsumoto +4 more
2020Scientific Reports15 citations Open access
Semantic Scholar
MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF
Nobuyuki Kondo, Takahiro Utsumi, Yuki Shimizu, Ai Takemoto +8 more
2023JCI Insight14 citations Open access
Semantic Scholar
The oncogene-dependent resistance to reprogramming unveils cancer therapeutic targets.
K. Ito, Kohei Nagata, Sho Ohta, Yutaka Matsuda +13 more
2022Cell Reports14 citations Open access
Semantic Scholar
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells
Ming-Jue Chen, T. Mashima, Taichi Oishi, Y. Muramatsu +19 more
2023British Journal of Cancer12 citations Open access
Semantic Scholar
Systematic identification of ALK substrates by integrated phosphoproteome and interactome analysis
J. Adachi, A. Kakudo, Y. Takada, Junko Isoyama +8 more
2022Life Science Alliance12 citations Open access
Semantic Scholar
In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues.
Yuki Takahashi, Rii Morimura, K. Tsukamoto, Sayaka Gomi +11 more
2024Acta Biomaterialia11 citations Open access
Semantic Scholar
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK‐rearranged non–small cell lung cancer
T. Sakashita, N. Yanagitani, S. Koike, Siew-Kee Low +6 more
2022Cancer Science11 citations Open access
Semantic Scholar
Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR
R. Ariyasu, K. Uchibori, Takaaki Sasaki, M. Tsukahara +11 more
2021Cancer Science11 citations Open access
Semantic Scholar
Inhibition of anti-apoptotic Bcl-2 family members promotes synergistic cell death with ER stress inducers by disrupting autophagy in glioblastoma
Tianyi Huang, S. Takagi, S. Koike, Ryohei Katayama
2025Cell Death Discovery9 citations Open access
Semantic Scholar
Promoting Biological Similarity by Collagen Microfibers in 3D Colorectal Cancer-Stromal Tissue: Replicating Mechanical Properties and Cancer Stem Cell Markers.
Naoko Sasaki, Yoshiya Asano, Yukiko Sorayama, Chihiro Kamimura +5 more
2024Acta Biomaterialia9 citations Open access
Semantic Scholar
Novel resistance mechanisms including L1196Q, P1094H, and R1248_D1249insertion in three patients with non-small-cell lung cancer following ALK tyrosine kinase inhibitor treatment.
Hiromi Furuta, M. Araki, K. Masago, Yukari Sagae +9 more
2020Journal of Thoracic Oncology9 citations Open access
Semantic Scholar
AXL‐Mediated Drug Resistance in ALK‐Rearranged NSCLC Enhanced by GAS6 From Macrophages and MMP11 Positive Fibroblasts
Takahiro Utsumi, Hayato Mizuta, Yosuke Seto, K. Uchibori +3 more
2025Cancer Science8 citations Open access
Semantic Scholar
Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK‐inhibitor‐induced tolerant persister cells in ALK ‐fusion‐positive lung cancer
K. Furugaki, Takaaki Fujimura, Narumi Sakaguchi, Y. Watanabe +5 more
2024Molecular Oncology7 citations Open access
Semantic Scholar
Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer
Takaaki Fujimura, K. Furugaki, Hayato Mizuta, Satoshi Muraoka +7 more
2024npj Precision Oncology7 citations Open access
Semantic Scholar
Chromatin structure-dependent histone incorporation revealed by a genome-wide deposition assay
H. Tachiwana, M. Dacher, K. Maehara, Akihito Harada +6 more
2021eLife7 citations Open access
Semantic Scholar
Serine–arginine protein kinase-like protein, SrpkF, stimulates both cellobiose-responsive and d-xylose-responsive signaling pathways in Aspergillus aculeatus
Ryohei Katayama, Natsumi Kobayashi, T. Kawaguchi, S. Tani
2021Current Genetics6 citations Open access
Semantic Scholar
BET protein-dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.
Shun Morino, T. Mashima, Fumiyuki Shirai, Satoshi Nagayama +2 more
2024Cancer Letters5 citations Open access
Semantic Scholar
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma
S. Takagi, M. Nakajima, S. Koike, Miho Takami +12 more
2024Oncogene4 citations Open access
Semantic Scholar
3D layered co-culture model enhances Trastuzumab Deruxtecan sensitivity and reveals the combined effect with G007-LK in HER2-positive non-small cell lung cancer.
Akari Shiraishi, Tomoko Oh-hara, Yuki Takahashi, K. Uchibori +2 more
2024Biochemical and Biophysical Research Communications - BBRC4 citations Open access
Semantic Scholar
ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis.
M. Nagasaka, Chiharu Miyajima, Yasumichi Inoue, Sakura Hashiguchi +7 more
2024Biochemical and Biophysical Research Communications - BBRC4 citations Open access
Semantic Scholar
Novel knock‐in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin–targeting agents
Takao Ukaji, Ai Takemoto, Harumi Shibata, M. Kakino +3 more
2021Cancer Science4 citations Open access
Semantic Scholar
Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra‐Terminal Domain Inhibitors
Yosuke Miyashita, K. Tajima, Kenta Izumi, N. Matsumoto +17 more
2025Cancer Science3 citations Open access
Semantic Scholar
MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer.
Xinzhao Wei, K. Uchibori, Nobuyuki Kondo, Takahiro Utsumi +6 more
2024Cancer Letters3 citations Open access
Semantic Scholar
Identification of C-mannosylation in a receptor tyrosine kinase AXL
Kento Mori, Takehiro Suzuki, Urara Waki, Soichiro Hayashi +7 more
2024Glycobiology3 citations Open access
Semantic Scholar
NuclSeg: nuclei segmentation using semi-supervised stain deconvolution
Haixin Wang, Jian Yang, Ryohei Katayama, M. Matsusaki +2 more
2023ACM Multimedia Asia3 citations Open access
Semantic Scholar
Spatiotemporal commonality of the TCR repertoire in a T-cell memory murine model and in metastatic human colorectal cancer
M. Haraguchi, K. Kiyotani, Tomohiro Tate, S. Sakata +6 more
2023Cancer Immunology and Immunotherapy3 citations Open access
Semantic Scholar
Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancer.
K. Seto, J. Shimizu, K. Masago, M. Araki +9 more
2022Cancer Genetics3 citations Open access
Semantic Scholar
Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms
R. Ariyasu, N. Yanagitani, K. Tadokoro, Toshikazu Yamaguchi +5 more
2020Cancer Chemotherapy and Pharmacology3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Nishio×15
Invite
M. Nishio — researcher profile on SciRah
K. Uchibori×15
Invite
K. Uchibori — researcher profile on SciRah
N. Yanagitani×14
Invite
N. Yanagitani — researcher profile on SciRah
N. Fujita×10
Invite
N. Fujita — researcher profile on SciRah

×9

Invite

S. Koike — researcher profile on SciRah

Invite

Ai Takemoto — researcher profile on SciRah

Naoya Fujita×9

Invite

Naoya Fujita — researcher profile on SciRah

Invite

K. Takeuchi — researcher profile on SciRah

Invite

Yosuke Seto — researcher profile on SciRah

Invite

S. Takagi — researcher profile on SciRah

Invite

M. Araki — researcher profile on SciRah

Invite

T. Oh-hara — researcher profile on SciRah